Recruiting OBSERVATIONAL NCT05514028

Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin (OVAmiARN)

Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin - OVAmiARN Study

Sponsor: Monitoring Force Group

Conditions Borderline Ovarian Cancer Ovarian Cancer Ovarian Cyst Benign

Updated 5 times since 2022 Last updated: Apr 8, 2024 Started: May 4, 2022 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Borderline Ovarian Cancer and Ovarian Cancer, this trial is actively recruiting participants. The trial is conducted by Monitoring Force Group and has accumulated 5 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
May 2024 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Feb 2023 — May 2024 [monthly]

Not Yet Recruiting
Sep 2022 — Feb 2023 [monthly]

Not Yet Recruiting

First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Monitoring Force Group
ZIWIG
iGenSeq

Data source: ZIWIG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Angers, France , Bastia, France , Caen, France , Lyon, France , Nice, France , Niort, France , Paris, France , Rennes, France , Rouen, France , Toulouse, France and 1 more location